Bill

Bill > HB2318


OR HB2318

OR HB2318
Relating to mail order drugs.


summary

Introduced
01/13/2025
In Committee
01/17/2025
Crossed Over
Passed
Dead
06/27/2025

Introduced Session

2025 Legislative Measures

Bill Summary

The statement includes a measure digest written in compliance with applicable readability standards. Digest: The Act tells OHA to review studies about what happens when drugs get too hot or too cold during transit. (Flesch Readability Score: 72.3). Requires the Oregon Health Authority to review studies on temperature excursions during the transit of mail order drugs. Directs the authority to submit findings to the interim committees of the Legislative Assembly related to health care not later than September 15, 2026. Sunsets on January 2, 2027.

AI Summary

This bill requires the Oregon Health Authority (OHA) to conduct a comprehensive literature review focusing on how temperature changes during mail order drug transportation might affect drug effectiveness and patient safety. Specifically, the OHA will examine peer-reviewed, independently funded scientific studies about "temperature excursions" - a technical term referring to deviations from recommended storage temperatures. The review will explore potential risks to patient health and identify options to mitigate these risks. The authority is mandated to submit a report to the legislative health care committees by September 15, 2026, which may include recommendations for future legislation. The bill includes a sunset provision, meaning the requirement will automatically be repealed on January 2, 2027, effectively making this a temporary directive for the Oregon Health Authority to investigate and report on the potential impacts of temperature variations on mail-order medications.

Committee Categories

Health and Social Services

Sponsors (3)

Last Action

In committee upon adjournment. (on 06/27/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...